441 related articles for article (PubMed ID: 29878714)
1. Recurrence of Giant Cell Tumor of the Spine after Resection: A Report of 10 Cases.
Lin P; Lin N; Teng W; Wang SD; Pan WB; Huang X; Yan XB; Liu M; Li HY; Li BH; Sun LL; Wang Z; Zhou XZ; Ye ZM
Orthop Surg; 2018 May; 10(2):107-114. PubMed ID: 29878714
[TBL] [Abstract][Full Text] [Related]
2. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
3. Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine.
Yokogawa N; Murakami H; Demura S; Kato S; Yoshioka K; Shimizu T; Oku N; Kitagawa R; Tsuchiya H
Eur Spine J; 2018 Dec; 27(12):3084-3091. PubMed ID: 30209582
[TBL] [Abstract][Full Text] [Related]
4. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
5. Aneurysmal bone cyst secondary to giant cell tumor of the mobile spine: a report of 11 cases.
Wu Z; Yang X; Xiao J; Feng D; Huang Q; Zheng W; Huang W; Zhou Z
Spine (Phila Pa 1976); 2011 Oct; 36(21):E1385-90. PubMed ID: 21221054
[TBL] [Abstract][Full Text] [Related]
6. Recurrence Factors in Giant Cell Tumors of the Spine.
Ouyang HQ; Jiang L; Liu XG; Wei F; Yang SM; Meng N; Jiang P; Yu M; Wu FL; Dang L; Zhou H; Zhang H; Liu ZJ
Chin Med J (Engl); 2017 Jul; 130(13):1557-1563. PubMed ID: 28639571
[TBL] [Abstract][Full Text] [Related]
7. A system for surgical staging and management of spine tumors. A clinical outcome study of giant cell tumors of the spine.
Hart RA; Boriani S; Biagini R; Currier B; Weinstein JN
Spine (Phila Pa 1976); 1997 Aug; 22(15):1773-82; discussion 1783. PubMed ID: 9259790
[TBL] [Abstract][Full Text] [Related]
8. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
9. Analysis of risk factors for recurrence of giant cell tumor of the sacrum and mobile spine combined with preoperative embolization.
Ming Z; Kangwu C; Huilin Y; Genlin W; Jian L; Yiming J; Chunshen W; Chao C
Turk Neurosurg; 2013; 23(5):645-52. PubMed ID: 24101313
[TBL] [Abstract][Full Text] [Related]
10. [Case analysis on treatment and recurrence of giant cell tumor of bone].
Zhang Z; Zhu B; Sun T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
[TBL] [Abstract][Full Text] [Related]
11. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
[TBL] [Abstract][Full Text] [Related]
12. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?
Wysocki RW; Soni E; Virkus WW; Scarborough MT; Leurgans SE; Gitelis S
Clin Orthop Relat Res; 2015 Feb; 473(2):706-15. PubMed ID: 25472928
[TBL] [Abstract][Full Text] [Related]
13. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
[TBL] [Abstract][Full Text] [Related]
14. Treatment and outcome of malignant giant cell tumor in the spine.
Yin H; Cheng M; Li B; Li B; Wang P; Meng T; Wang J; Zhou W; Yan W; Xiao J
J Neurooncol; 2015 Sep; 124(2):275-81. PubMed ID: 26040486
[TBL] [Abstract][Full Text] [Related]
15. Chondrosarcoma of the mobile spine: report on 22 cases.
Boriani S; De Iure F; Bandiera S; Campanacci L; Biagini R; Di Fiore M; Bandello L; Picci P; Bacchini P
Spine (Phila Pa 1976); 2000 Apr; 25(7):804-12. PubMed ID: 10751291
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.
Wang QZ; Zhang EL; Xing XY; Su MY; Lang N
Orthop Surg; 2021 Dec; 13(8):2405-2416. PubMed ID: 34841660
[TBL] [Abstract][Full Text] [Related]
17. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature.
Martin C; McCarthy EF
Iowa Orthop J; 2010; 30():69-75. PubMed ID: 21045974
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor.
Ruggieri P; Mavrogenis AF; Ussia G; Angelini A; Papagelopoulos PJ; Mercuri M
Clin Orthop Relat Res; 2010 Nov; 468(11):2954-61. PubMed ID: 20623262
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
